The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary Due To COVID-19: a Case Series

INTRODUCTION: Inhaled epoprostenol (iEpo) is a pulmonary vasodilator used to treat refractory respiratory failure, including that caused by Coronavirus 2019 (COVID-19) pneumonia. AIM OF STUDY: To describe the experience at three teaching hospitals using iEpo for severe respiratory failure due to COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Imtiaz, Komal, Jodeh, Wade, Sudekum, Dave, DiGiovine, Bruno, Hecht, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852286/
https://www.ncbi.nlm.nih.gov/pubmed/35274053
http://dx.doi.org/10.2478/jccm-2021-0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852286/
https://www.ncbi.nlm.nih.gov/pubmed/35274053
http://dx.doi.org/10.2478/jccm-2021-0037

Ejemplares similares